ETN
61
2
GS
78
2
F
58
2
MO
57
4
AZO
46
-2
IBM
67
2
EXC
53
3
TSN
47
3
PX
55
2
CSX
50
2
DRI
64
4
IFF
62
5
EXPD
48
-2
GRMN
40
3
PLD
33
3
HPE
68
-5
ALLE
48
2
DVN
40
-2
LOW
45
2
SO
53
5
ETN
61
2
GS
78
2
F
58
2
MO
57
4
AZO
46
-2
IBM
67
2
EXC
53
3
TSN
47
3
PX
55
2
CSX
50
2
DRI
64
4
IFF
62
5
EXPD
48
-2
GRMN
40
3
PLD
33
3
HPE
68
-5
ALLE
48
2
DVN
40
-2
LOW
45
2
SO
53
5
Financhill
Back

Regional Management Corp. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
75

RM
Regional Management Corp.

Last Price:
$40.37
Seasonality Move:
-0.03%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
75
Regional Management Corp. (RM) is a Buy

Is Regional Management Corp. a Buy, Sell or Hold?

  • The current Regional Management Corp. [RM] share price is $40.55. The Score for RM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • RM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RM Stock Price Chart

What is Regional Management Corp.'s stock price today?

  • The Regional Management Corp. share price today is $40.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RM is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

RM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.59 Buy
Relative Strength Index (14 RSI): 60.69 Buy
Chaikin Money Flow: 25852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.78 - 39.74) Buy
Bollinger Bands (100): (36.99 - 41.99) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

RM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.88 Buy
20-day SMA: 38.65 Buy
50-day SMA: 38.62 Buy
200-day SMA: 34.79 Buy
8-day EMA: 31.31 Buy
20-day EMA: 18.11 Buy
50-day EMA: 8.55 Buy
200-day EMA: 2.33 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Regional Management Corp. Earnings Growth & RM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $1.70 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Regional Management Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):